Cross-Sector entity
Dentsply Sirona is the most frequent co-covered peer, appearing in 3 of the 5 tracked stories. The 149-day window averages about 0.2 stories each week. The busiest single day carried 3. Coverage clusters in acquisition, which accounts for 1 of those 5, with the remainder spread across 4 other categories.
5 verified stories tracked
Last mentioned: Jul 15, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 20 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Dentsply Sirona is the most frequent co-covered peer, appearing in 3 of the 5 tracked stories. The 149-day window averages about 0.2 stories each week. The busiest single day carried 3. Coverage clusters in acquisition, which accounts for 1 of those 5, with the remainder spread across 4 other categories. Global Payments appears in 5 tracked Cross-Sector stories published from February 17, 2026 through July 15, 2026. Negative sentiment appears in 0% of the tracked stories. Each carries 2.6 original sources on average.
Computed from the 5 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Global Payments. Shared-story counts are live from our verified record — not editorial picks.
The joint $53.4 billion bid by Stripe and Advent to acquire PayPal would create a payments behemoth processing over $3.7 trillion annually, directly impacting the SaaS ecosystem. For cloud businesses relying on Stripe’s APIs or PayPal’s checkout, a merger could unify fragmented payment rails, introduce new cross-sell opportunities, and alter competitive dynamics among payment processors.
Invenomic Capital Management has fully liquidated its $24.3 million stake in Haemonetics Corporation (HAE) following a period of significant market underperformance. The move signals a strategic shift for the fund as it reallocates capital toward more resilient healthcare and technology holdings.
Invenomic Capital Management has fully liquidated its $24.29 million position in Haemonetics Corporation, signaling a shift away from the underperforming medical device maker. The exit comes as Haemonetics shares have lagged the broader market, dropping 9% over the past year while the fund rotates capital into diversified healthcare and technology plays.
Invenomic Capital Management has fully liquidated its $24.29 million position in Haemonetics Corporation, a leader in blood and plasma management technology. The exit comes as the stock underperformed the broader market by 25% over the past year, signaling a shift in institutional sentiment toward the medical device sector.
Source: Jonathan Ponciano (us) · fool.com
Global-E Online and Global Payments are preparing to report Q4 2025 results, offering a critical look at cross-border e-commerce momentum and the success of software-led payment strategies. These reports will serve as a barometer for global consumer spending resilience at the close of the fiscal year.
Source: Seeking Alpha · Seeking Alpha
